STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #449 by analyst upside · 2026-06-27
MLSS
Milestone Scientific Inc.
Healthcare · Market Cap $28M · P/E 0x
ANALYST PRICE TARGET
+212.8%
implied upside to consensus target
Current Price $0.32
Consensus Target $1.0
Bull Target $1.0
Bear Target $1.0
Analysts Covering 2
ANALYST CONSENSUS — STRONG BUY
Strong Buy
1
Buy
1
Hold
0
Sell
0
52-Week Low $0.22
52-Week High $0.81
YTD Return +10.2%
FUNDAMENTALS
Market Cap $28M
P/E Ratio (TTM) N/A
Forward P/E -9.1x
EPS (TTM) $-0.06
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $9M
Profit Margin -51.3%
52-WEEK RANGE
52-Week Low $0.22
52-Week High $0.81
Current Price $0.32
Bear Target $1.0
Bull Target $1.0
● Now $0.32 ● Target $1.0
TRADING DATA
Avg Volume 2.1M
YTD Return +10.2%
Analyst Count 2
Consensus Strong Buy
Upside to Target +212.8%
Last Updated 2026-06-27

ANALYST SUMMARY

Milestone Scientific Inc. (MLSS) is currently trading at $0.32 with a Wall Street consensus price target of $1.0, implying potential upside of 212.8% over the next 12 months. 2 analysts currently cover MLSS, with a consensus rating of Strong Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1.0, while the most cautious has a target of $1.0.

MLSS operates in the Healthcare sector with a market capitalisation of $28M. The stock is up 10.2% year-to-date and is currently trading near the lower end of its 52-week range of $0.22 – $0.81.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MLSS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Benchmark — Reiterated
Speculative Buy → Speculative Buy 2025-11-20 Building track record
Benchmark reit
Speculative Buy → Speculative Buy 2024-11-20 Building track record
Benchmark ● Initiated
Speculative Buy 2024-10-10 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →